More specifically, Metrnl has been documented to be associated with lowered pro-inflammatory cytokine production, such as TNF-α and IL-6 [18, 32], which has also been observed in our study among CAD patients who underwent exercises during a 12-week period, compared to pre-exercise levels. Here, IL6 is linked to coronary artery disorder.